503A Pharmacies
Compounding pharmacies and 503A specialty pharmacies have been the center of FDA (U.S. Food & Drug Administration) focus ever since the tragic 64 deaths associated with the NECC (New England Compounding Center) occurred back in 2012. The 64 patients that died and the 750+ others that were injure